Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caligiuri

Showing results (981-990 of 1,066) with videos related to

Pageof 107
Sort By:
Blood|September 16, 2010
BAALC and ERG expression levels are associated with outcome and distinct gene and microRNA expression profiles in older patients with de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B studySebastian Schwind, Guido Marcucci, Kati Maharry, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 14, 2003
A pilot study of high-throughput, sequence-based mutational profiling of primary human acute myeloid leukemia cell genomesTimothy J Ley, Patrick J Minx, Matthew J Walter, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 27, 2017
IL-18 Drives ILC3 Proliferation and Promotes IL-22 Production via NF-κBAaron R Victor, Ansel P Nalin, Wenjuan Dong, et al.
Cell Reports. Medicine|January 26, 2021
Epitope-resolved profiling of the SARS-CoV-2 antibody response identifies cross-reactivity with endemic human coronavirusesJason T Ladner, Sierra N Henson, Annalee S Boyle, et al.
Cancers|June 10, 2023
Follicular Helper and Regulatory T Cells Drive the Development of Spontaneous Epstein-Barr Virus Lymphoproliferative DisorderElshafa Hassan Ahmed, Mark Lustberg, Claire Hale, et al.
Biorxiv : the Preprint Server for Biology|August 4, 2020
Epitope-resolved profiling of the SARS-CoV-2 antibody response identifies cross-reactivity with an endemic human CoVJason T Ladner, Sierra N Henson, Annalee S Boyle, et al.
Blood|October 24, 2002
Phase 1 and pharmacodynamic studies of G3139, a Bcl-2 antisense oligonucleotide, in combination with chemotherapy in refractory or relapsed acute leukemiaGuido Marcucci, John C Byrd, Guowei Dai, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 4, 2012
RUNX1 mutations are associated with poor outcome in younger and older patients with cytogenetically normal acute myeloid leukemia and with distinct gene and MicroRNA expression signaturesJason H Mendler, Kati Maharry, Michael D Radmacher, et al.
Leukemia|June 15, 2013
A stem cell-like gene expression signature associates with inferior outcomes and a distinct microRNA expression profile in adults with primary cytogenetically normal acute myeloid leukemiaK H Metzeler, K Maharry, J Kohlschmidt, et al.
Blood|August 24, 2013
Preclinical and clinical efficacy of XPO1/CRM1 inhibition by the karyopherin inhibitor KPT-330 in Ph+ leukemiasChristopher J Walker, Joshua J Oaks, Ramasamy Santhanam, et al.
Pageof 107

Showing results (981-990 of 1,066) with videos related to

Sort By:
Pageof 107
Blood|September 16, 2010
BAALC and ERG expression levels are associated with outcome and distinct gene and microRNA expression profiles in older patients with de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B studySebastian Schwind, Guido Marcucci, Kati Maharry, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 14, 2003
A pilot study of high-throughput, sequence-based mutational profiling of primary human acute myeloid leukemia cell genomesTimothy J Ley, Patrick J Minx, Matthew J Walter, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 27, 2017
IL-18 Drives ILC3 Proliferation and Promotes IL-22 Production via NF-κBAaron R Victor, Ansel P Nalin, Wenjuan Dong, et al.
Cell Reports. Medicine|January 26, 2021
Epitope-resolved profiling of the SARS-CoV-2 antibody response identifies cross-reactivity with endemic human coronavirusesJason T Ladner, Sierra N Henson, Annalee S Boyle, et al.
Cancers|June 10, 2023
Follicular Helper and Regulatory T Cells Drive the Development of Spontaneous Epstein-Barr Virus Lymphoproliferative DisorderElshafa Hassan Ahmed, Mark Lustberg, Claire Hale, et al.
Biorxiv : the Preprint Server for Biology|August 4, 2020
Epitope-resolved profiling of the SARS-CoV-2 antibody response identifies cross-reactivity with an endemic human CoVJason T Ladner, Sierra N Henson, Annalee S Boyle, et al.
Blood|October 24, 2002
Phase 1 and pharmacodynamic studies of G3139, a Bcl-2 antisense oligonucleotide, in combination with chemotherapy in refractory or relapsed acute leukemiaGuido Marcucci, John C Byrd, Guowei Dai, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 4, 2012
RUNX1 mutations are associated with poor outcome in younger and older patients with cytogenetically normal acute myeloid leukemia and with distinct gene and MicroRNA expression signaturesJason H Mendler, Kati Maharry, Michael D Radmacher, et al.
Leukemia|June 15, 2013
A stem cell-like gene expression signature associates with inferior outcomes and a distinct microRNA expression profile in adults with primary cytogenetically normal acute myeloid leukemiaK H Metzeler, K Maharry, J Kohlschmidt, et al.
Blood|August 24, 2013
Preclinical and clinical efficacy of XPO1/CRM1 inhibition by the karyopherin inhibitor KPT-330 in Ph+ leukemiasChristopher J Walker, Joshua J Oaks, Ramasamy Santhanam, et al.
Pageof 107